These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1315395)

  • 1. Novel naphthalenic ligands with high affinity for the melatonin receptor.
    Yous S; Andrieux J; Howell HE; Morgan PJ; Renard P; Pfeiffer B; Lesieur D; Guardiola-Lemaitre B
    J Med Chem; 1992 Apr; 35(8):1484-6. PubMed ID: 1315395
    [No Abstract]   [Full Text] [Related]  

  • 2. [New naphthalenic ligands of melatoninergic receptors].
    Adam G; Guardiola-Lemaitre B; Yous S; Lesieur D; Morgan P; Howell HE; Andrieux J; Caignard DH; Pfeiffer B; Renard P
    J Pharm Belg; 1992; 47(4):374-80. PubMed ID: 1328595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sites.
    Langlois M; Brémont B; Shen S; Poncet A; Andrieux J; Sicsic S; Serraz I; Mathé-Allainmat M; Renard P; Delagrange P
    J Med Chem; 1995 Jun; 38(12):2050-60. PubMed ID: 7783136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
    Leclerc V; Fourmaintraux E; Depreux P; Lesieur D; Morgan P; Howell HE; Renard P; Caignard DH; Pfeiffer B; Delagrange P; Guardiola-Lemaître B; Andrieux J
    Bioorg Med Chem; 1998 Oct; 6(10):1875-87. PubMed ID: 9839017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
    Descamps-François C; Yous S; Chavatte P; Audinot V; Bonnaud A; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
    J Med Chem; 2003 Mar; 46(7):1127-9. PubMed ID: 12646022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
    Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
    Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(125I) iodomelatonin binding sites in rat adrenals: pharmacological characteristics and subcellular distribution.
    Persengiev SP
    Life Sci; 1992; 51(9):647-51. PubMed ID: 1323736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin receptors.
    Krause DN; Dubocovich ML
    Annu Rev Pharmacol Toxicol; 1991; 31():549-68. PubMed ID: 1648339
    [No Abstract]   [Full Text] [Related]  

  • 9. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
    Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
    Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.
    Mathé-Allainmat M; Le Gall M; Jellimann C; Andrieux J; Langlois M
    Bioorg Med Chem; 1999 Dec; 7(12):2945-52. PubMed ID: 10658600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [125I]-labelled iodomelatonin binding sites in the duck bursa of Fabricius: binding characteristics and diurnal variation.
    Liu ZM; Pang SF
    Neurosci Lett; 1992 Nov; 146(2):163-6. PubMed ID: 1337193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
    Sun LQ; Chen J; Bruce M; Deskus JA; Epperson JR; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3799-802. PubMed ID: 15203165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological identity of 2-[125I]iodomelatonin binding sites in chicken brain and sheep pars tuberalis.
    Sugden D; Chong NW
    Brain Res; 1991 Jan; 539(1):151-4. PubMed ID: 1849778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin binding sites: are they receptors?
    Kennaway DJ; Hugel HM
    Mol Cell Endocrinol; 1992 Oct; 88(1-3):C1-9. PubMed ID: 1334003
    [No Abstract]   [Full Text] [Related]  

  • 15. The chick retinal melatonin receptor revisited: localization and modulation of agonist binding with guanine nucleotides.
    Laitinen JT; Saavedra JM
    Brain Res; 1990 Oct; 528(2):349-52. PubMed ID: 2176912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and characterization of melatonin receptors in the brain of the Japanese quail, Coturnix japonica.
    Cozzi B; Stankov B; Viglietti-Panzica C; Capsoni S; Aste N; Lucini V; Fraschini F; Panzica GC
    Neurosci Lett; 1993 Feb; 150(2):149-52. PubMed ID: 8385754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-[125I]iodomelatonin labels sites with identical pharmacological characteristics in chicken brain and chicken retina.
    Dubocovich ML; Shankar G; Mickel M
    Eur J Pharmacol; 1989 Mar; 162(2):289-99. PubMed ID: 2542059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constant light exposure increases 2-[125I]iodomelatonin binding sites in the guinea pig spleen.
    Poon AM; Pang SF
    Neurosci Lett; 1992 Oct; 146(1):41-4. PubMed ID: 1335561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic melatonin receptor sites revealed by autoradiography.
    Vanĕcek J; Pavlík A; Illnerová H
    Brain Res; 1987 Dec; 435(1-2):359-62. PubMed ID: 2827856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of 2-[125I]iodomelatonin-binding sites in quail testes at mid-light and mid-dark.
    Wang ZP; Cheng KM; Brown GM; Pang CS; Pang SF
    Neurosci Lett; 1992 Nov; 146(2):195-8. PubMed ID: 1337195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.